glp-1 atrial fibrillation Impact of Receptor Agonist Therapy on Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis Mechanisms of GLP-1 Receptor Agonists

After that, a single daily injection maintains relatively flat insulin coverage for 24 to 36 hours

How do we balance having these conversations, having these interactions with patients, responsible prescribing of medications as part of a weight loss journey and a lifestyle journey

You should always seek medical advice from a healthcare professional for any questions or concerns about your medical condition or treatment

In the ATTAIN-1 Phase 3 trial, the most frequently reported adverse events with orforglipron 36 mg versus placebo were nausea (33.7% vs 10.4%), constipation (25.4% vs 9.3%), diarrhea (23.1% vs 9.6%), and vomiting (24.0% vs 4.0%)

Limit added sugars and highly processed foods, which can trigger cravings even on appetite-suppressing medications